Duodenoscopes Market Size & Share 2026-2035

Duodenoscopes Market Size

The global duodenoscopes market was valued at USD 191 million in 2025. The market is expected to reach from USD 201 million in 2026 to USD 335.4 million in 2035, growing at a CAGR of 5.9% during the forecast period, according to the latest report published by Global Market Insights Inc.

Growing adoption of minimally invasive procedures, increasing prevalence of gastrointestinal disorders, rise in therapeutic applications and focus on infection prevention are among the key factors fueling the market growth. Duodenoscopes are specialized, flexible endoscopic devices used for examining and treating conditions in the duodenum, which is the first section of the small intestine. They are primarily employed in a procedure known as endoscopic retrograde cholangiopancreatography (ERCP), which involves diagnosing and treating problems in the bile ducts, pancreatic ducts, and gallbladder.
 

The key players in the duodenosocpe market are Ambu, Boston Scientific Corporation, Fujifilm Holdings Corporation, Olympus Corporation, and STORZ. These players compete in the market through incremental innovation, expanded distribution channels, and the integration of enhanced visualization technologies, disposable components, and infection-control focused designs to improve procedural safety and clinical outcomes in endoscopic interventions.
 

The market has increased from USD 157.4 million in 2022 to USD 180.8 million in 2024, with a historic growth rate of 17.5%. The market has shown steady expansion in recent years, supported by the increasing prevalence of gastrointestinal disorders and the rise in therapeutic applications and focus on infection prevention.
 

Increasing awareness about gastrointestinal health and early screening programs is driving demand for diagnostic procedures. Widespread availability of medical insurance in developed economies encourages patients to opt for advanced diagnostic techniques. For instance, according to the stats reported by GI Alliance, around 20 million Americans suffer from chronic digestive diseases. The growing global burden of gastrointestinal diseases is directly increasing the demand for diagnostic and therapeutic procedures involving duodenoscopes.
 

The aging demographic worldwide is more susceptible to gastrointestinal and hepatopancreaticobiliary conditions, increasing the demand for diagnostic tools like duodenoscopes. In addition, growing use of duodenoscopes for therapeutic procedures like stent placements, stone removals, and management of strictures is increasing the device's utility and market demand.
 

Duodenoscopes Market Trends

Technological advancements are revolutionizing the duodenoscope market by addressing key concerns such as safety, image quality, and usability. These innovations not only improve clinical outcomes but also enhance patient and clinician satisfaction.
 

• Compact and portable duodenoscope models are ideal for ASCs and outpatient settings, supporting the shift toward cost-effective healthcare delivery. Additionally, duodenoscopes with wireless capabilities enable real-time transmission of diagnostic data to remote locations, supporting telemedicine.
   
• Duodenoscopes with enhanced working channels and accessories allow for seamless transition between diagnostic and therapeutic applications. New models are designed to handle an expanded range of therapeutic procedures, increasing their utility and demand.
   
• Moreover, advanced duodenoscopes now offer superior image quality, aiding in accurate diagnosis and improved therapeutic outcomes. It enhances visualization of mucosal and vascular structures, allowing for better detection of abnormalities.
   

Duodenoscopes Market Analysis

Based on product type, the market is segmented as reusable duodenoscopes and single-use duodenoscopes. The reusable duodenoscopes segment is expected to drive business growth and expand at a CAGR of 5.6%, reaching over USD 253.7 million by 2035.
 

• Reusable duodenoscopes are more cost-effective for high-volume healthcare facilities, as the initial investment is offset by repeated use over time. Facilities in low- to middle-income regions often prefer reusable models due to budget limitations. Modern reusable duodenoscopes feature removable components to facilitate thorough cleaning and reduce the risk of cross-contamination.
   
• Moreover, reusable duodenoscopes with integrated high-definition video and advanced imaging features remain indispensable for complex diagnostic and therapeutic procedures.
   
• Furthermore, single-use duodenoscopes are not yet available across all regions and countries and remain cost-prohibitive for many facilities, thus driving the demand for reusable devices.
   
• The single-use duodenoscopes segment was valued at USD 42.8 million in 2025 and is expected to reach USD 81.7 million by 2035. The segment is gaining traction due to growing concerns over cross-contamination and infection risks associated with reusable scopes, along with increasing regulatory emphasis on patient safety and reprocessing standards. Additionally, the elimination of complex sterilization procedures and improved workflow efficiency in endoscopy units are encouraging healthcare facilities to adopt disposable duodenoscopes, particularly in high-risk and high-volume clinical settings.
   

Based on category, the duodenoscopes market is segmented as video duodenoscopes and fiber optic duodenoscopes. The video duodenoscopes segment accounted for the leading revenue share and was valued at around USD 165.1 million in 2025.
 

• Video duodenoscopes provide superior visualization of the gastrointestinal tract, aiding in precise diagnosis and treatment. Enhanced imaging capabilities allow for real-time assessment and decision-making during procedures. Additionally, advanced visualization technologies, like NBI, improve the detection of vascular and mucosal abnormalities, further driving demand.
   
• Video duodenoscopes are integral to minimally invasive procedures like ERCP, which have gained traction due to their lower risk and faster recovery times compared to open surgery.
   
• Moreover, AI-driven diagnostics, autofluorescence imaging, and augmented reality overlays enhance the diagnostic accuracy of video duodenoscopes. Further, newer models are lighter and more user-friendly, making them suitable for prolonged procedures.
   
• The fiber optic duodenoscopes segment was valued at USD 26 million in 2025 and is expected to grow at a CAGR of 4.4% during the forecast period. The segment continues to hold relevance due to its cost-effectiveness, durability, and established clinical familiarity across healthcare facilities, particularly in resource-constrained settings. Moreover, ongoing use in routine endoscopic procedures and gradual upgrades to imaging clarity and ergonomic design are expected to support steady, albeit moderate, growth over the forecast timeline.
   

Based on sales channel, the duodenoscopes market is segmented as direct sales and distributors. The direct sales segment is expected to drive business growth and expand at a CAGR of 6.1%, reaching around USD 231.2 million by 2035.
 

• Direct sales teams can provide on-site training and technical assistance, ensuring that medical staff are proficient in using the devices, especially for complex equipment like duodenoscopes.
   
• Direct sales models can help manufacturers better control the quality of service and customer experiences, contributing to stronger brand loyalty among end users.
   
• Further, direct sales remove the cost of intermediaries, making it more economical for the manufacturer to engage with customers. Manufacturers can set more consistent pricing strategies and avoid the potential markups that distributors might add, resulting in higher profit margins.
   
• The distributors segment was valued at USD 62.7 million in 2025 and is expected to grow at a CAGR of 5.3% during the forecast period. Growth is driven by the critical role distributors play in ensuring timely product availability, inventory management, and technical support across hospitals and ambulatory endoscopy centers. Additionally, strong regional distribution networks and partnerships with device manufacturers are expected to enhance market penetration, particularly in emerging healthcare markets with expanding endoscopic procedure volumes.
   

Based on end use, the duodenoscopes market is classified into hospitals, ambulatory surgical centers (ASCs), and other end users. The hospitals segment dominated the market with a revenue share of 75.1% in 2025.
 

• Hospitals see a high number of patients with gastrointestinal issues such as bile duct stones, pancreatic cancer, and biliary strictures, which require advanced diagnostic and therapeutic procedures like endoscopic retrograde cholangiopancreatography (ERCP), a key application of duodenoscopes. Additionally, hospitals with specialized gastrointestinal (GI) departments or endoscopy units are more likely to invest in high-quality duodenoscopes, both for diagnostic and therapeutic purposes.
• Hospitals use duodenoscopes due to their ability to provide high-definition, real-time imaging for complex diagnostic tasks, which is crucial for ensuring patient safety and achieving accurate diagnoses.
  
   
• The ambulatory surgical centers (ASCs) segment was valued at USD 32.6 million in 2025 and is expected to reach USD 61.2 million by 2035. The segment is expanding due to the growing shift of minimally invasive gastrointestinal procedures toward outpatient settings, driven by cost efficiency and reduced hospital stay requirements. Increasing adoption of advanced endoscopic equipment, including single-use duodenoscopes, along with rising patient preference for same-day procedures, is expected to support sustained growth across ASCs over the forecast period.
  
   
• The other end users segment was valued at USD 15 million in 2025 and is poised to witness growth over the coming years. Growth is supported by increasing utilization of duodenoscopy procedures in specialized gastroenterology clinics and diagnostic centers focusing on early detection and routine evaluation of biliary and pancreatic conditions. Additionally, improving access to endoscopic services, rising referral volumes, and gradual investment in advanced imaging equipment are expected to contribute to steady segment expansion.
   

North America Duodenoscopes Market

North America dominated the market with the highest market share of 41.6% in 2025.
 

• The U.S. market was valued at USD 63.8 million and USD 67.9 million in 2022 and 2023, respectively. The market size reached USD 74.5 million in 2025, growing from USD 71.4 million in 2024, and is anticipated to grow at a CAGR of 4.3% from 2026 to 2035.
   
• The U.S. has a high incidence of gastrointestinal diseases, such as pancreatitis, gallstones, bile duct obstructions, and pancreatic cancer. These conditions require procedures such as ERCP which is performed by duodenoscopes.
   
• Additionally, technological advancements in video duodenoscopes, including high-definition imaging, narrow band imaging (NBI), and artificial intelligence (AI), are driving demand for more accurate diagnostics. Hospitals and healthcare facilities in the U.S. are investing in these advanced tools to improve patient outcomes and procedural accuracy.
   

Europe Duodenoscopes Market

Europe market accounted for USD 51.9 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe represents a significant share of the market, supported by well-established healthcare systems and a high volume of endoscopic procedures across countries such as Germany, France, and the UK. The increasing prevalence of gastrointestinal disorders, along with strong clinical adoption of advanced endoscopy techniques, has contributed to sustained demand for both reusable and single-use duodenoscopes in the region.
   
• Additionally, heightened focus on infection control and patient safety has accelerated the adoption of disposable and hybrid scope designs. Regulatory guidance emphasizing reprocessing standards and hospital-acquired infection prevention continues to encourage healthcare facilities to upgrade endoscopic equipment, supporting steady market growth across Europe.
   

Asia Pacific Duodenoscopes Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7.4% during the analysis timeframe.
 

• Asia Pacific is projected to witness robust growth in the market, driven by a large patient population, rising incidence of biliary and pancreatic diseases, and improving healthcare infrastructure. Rapid expansion of tertiary care hospitals and growing awareness of minimally invasive procedures are increasing procedural volumes across key markets such as China, Japan, and India.
   
• Furthermore, government investments in healthcare modernization and the gradual expansion of private healthcare providers are enhancing access to advanced endoscopy services. The region is also experiencing growing demand for cost-effective and durable duodenoscope solutions, creating opportunities for both global manufacturers and regional suppliers..
   

Latin America Duodenoscopes Market

The Latin America market accounted for USD 8.9 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Latin America holds a notable position in the market, supported by gradual improvements in healthcare infrastructure and increasing availability of specialized gastroenterology services. Countries such as Brazil and Mexico are witnessing rising demand for diagnostic and therapeutic endoscopic procedures, driven by the growing burden of gastrointestinal disorders.
   
• Additionally, expanding private healthcare networks and partnerships with international device manufacturers are improving access to advanced endoscopic technologies. While budget constraints in certain public healthcare settings may limit the rapid adoption of premium devices, the market is expected to grow steadily with increasing investment in endoscopy capabilities.
   

Middle East and Africa Duodenoscopes Market

The Middle East and Africa market accounted for USD 5.5 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The Middle East & Africa market is emerging, with growth largely concentrated in urban healthcare centers and countries investing heavily in medical infrastructure, such as the UAE and Saudi Arabia. Rising awareness of minimally invasive diagnostic and therapeutic procedures is supporting the gradual adoption of advanced endoscopic equipment in tertiary hospitals.
   
• Moreover, ongoing healthcare modernization initiatives and increasing medical tourism in select Middle Eastern countries are encouraging investment in high-quality endoscopy systems. Although disparities in healthcare access persist across parts of Africa, improving training programs and infrastructure development are expected to create long-term growth opportunities for the market in the region.
   

Duodenoscopes Market Share

The global market is consolidated, dominated by a small group of established medical device manufacturers who control the majority of product development, regulatory influence, and technological innovation, shaping market standards and competitive dynamics. Key companies in the duodenoscope market, including Olympus Corporation, Fujifilm Holdings Corporation, Ambu, and Boston Scientific Corporation, collectively account for approximately 52% of the global market share. These companies focus on enhancing product quality through advanced technologies. They prioritize the development of video duodenoscopes with high-definition imaging and single-use duodenoscopes to address infection control concerns.
 

Additionally, these companies are investing in minimally invasive technologies to improve patient outcomes and recovery times. Efforts to expand their product portfolio, ensure regulatory compliance, and cater to the growing demand in emerging markets like China and India are also key strategic focuses.
 

Duodenoscopes Market Companies

A few of the prominent players operating in the duodenoscopes industry include:

• Ambu
• Boston Scientific Corporation 
• Fujifilm Holdings Corporation
• Olympus Corporation
• Ottomed Endoscopy
• PENTAX MEDICAL
• SonoScape
• STORZ
   
• Ambu

Ambu’s unique strength lies in its pioneering leadership in single‑use endoscopy, with innovative disposable duodenoscopes such as the aScope Duodeno 2 designed to eliminate cross‑contamination risks, meet stringent infection‑control standards, and provide a sterile, ready‑to‑use solution for every ERCP procedure, positioning the company at the forefront of the global shift toward safer, reprocessing‑free endoscopy.
 

• Boston Scientific

Boston Scientific differentiates itself with its EXALT Model D, the world’s first FDA‑cleared single‑use duodenoscope, combining breakthrough‑designation innovation, a familiar reusable‑scope form factor, and strong clinical validation to deliver high‑quality ERCP performance while eliminating reprocessing burdens, enabling hospitals to significantly reduce infection risk and transition seamlessly to next‑generation disposable endoscopy.
 

• OLYMPUS

Olympus maintains a competitive edge through its longstanding dominance in reusable duodenoscopy, backed by advanced imaging technologies, deep clinical trust, and a broad ERCP device ecosystem; the company’s continuous innovation in video‑endoscopy platforms and high‑performance duodenoscopes reinforces its leadership in diagnostic and therapeutic GI procedures across global hospital systems.
 

Duodenoscopes Industry News

• In August 2024, PENTAX Medical, a division of HOYA group, announced that it had received FDA clearance for its DEC Duodenoscope compatible with the STERRAD 100NX Sterilizer, a product of Advanced Sterilization Products (ASP). This partnership between Pentax and ASP may enable the improvement of the ongoing challenges of duodenoscope reprocessing.
   
• In April 2024, Ambu announced that it had received FDA clearance for its new generation duodenoscopy solution, Ambu aScope Duodeno 2 and Ambu aBox 2, to be used in ERCP procedures. This development may allow the company to expand its product basket and enhance its industry presence.
   

The duodenoscopes market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Reusable duodenoscopes
• Single-use duodenoscopes

Market, By Category

• Video duodenoscopes
• Fiber optic duodenoscopes

Market, By Sales Channel

• Direct sales
• Distributors

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE